Viridian Therapeutics Inc (VRDN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 87,082 | 88,515 | 155,579 | 344,210 | 31,293 |
| Marketable Securities | 247,209 | 285,343 | 268,971 | 87,112 | 129,914 |
| Other current assets | 102 | 128 | 102 | 398 | 693 |
| TOTAL | $346,331 | $382,602 | $431,173 | $437,355 | $166,151 |
| Non-Current Assets | |||||
| PPE Net | 1,882 | 1,590 | 1,326 | 825 | 749 |
| Other Non-Current Assets | 3,254 | 2,450 | 2,592 | 2,400 | 2,914 |
| TOTAL | $5,136 | $4,040 | $3,918 | $3,225 | $3,663 |
| Total Assets | $351,467 | $386,642 | $435,091 | $440,580 | $169,814 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,133 | 7,872 | 14,234 | 12,152 | 4,061 |
| Accrued Expenses | 24,236 | 21,428 | 18,827 | 12,774 | 17,039 |
| TOTAL | $28,657 | $29,588 | $33,349 | $25,214 | $21,388 |
| Non-Current Liabilities | |||||
| Long Term Debt | 4,709 | 4,677 | 4,645 | 4,613 | 4,585 |
| Deferred Revenues | 288 | 288 | 288 | 288 | 288 |
| Other Non-Current Liabilities | 1,527 | 1,039 | 1,172 | 813 | 938 |
| TOTAL | $6,953 | $6,505 | $6,678 | $6,359 | $6,528 |
| Total Liabilities | $35,610 | $36,093 | $40,027 | $31,573 | $27,916 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 43,670 | 43,132 | 42,898 | 40,248 | 28,464 |
| Common Shares | 436 | 431 | 414 | 402 | 285 |
| Retained earnings | -611,388 | -556,325 | -488,174 | -442,389 | -413,484 |
| Other shareholders' equity | 134,739 | 134,738 | 141,757 | 141,207 | 102,401 |
| TOTAL | $315,857 | $350,549 | $395,064 | $409,007 | $141,898 |
| Total Liabilities And Equity | $351,467 | $386,642 | $435,091 | $440,580 | $169,814 |